A soluble form of Siglec-9 provides an antitumor benefit against mammary tumor cells expressing MUC1 in transgenic mice.
暂无分享,去创建一个
M. Morimatsu | K. Nishijima | Toshihiro Ito | Sayo Yamamoto | K. Ozaki | Y. Tomioka | Haruka Suyama | E. Ono | T. Usui